XML 47 R23.htm IDEA: XBRL DOCUMENT v3.24.1
Fair Value Measurements (Tables)
12 Months Ended
Dec. 31, 2023
Fair Value Disclosures [Abstract]  
Schedule of fair value assets measured on a recurring basis
The following table presents the Company’s financial assets and liabilities that are measured at fair value on a recurring basis and the level of inputs used in such measurements (in thousands):
 
    
December 31, 2023
 
    
Balance
    
Quoted Prices
in Active
Markets
(Level 1)
    
Significant
Other
Observable
Inputs (Level 2)
    
Significant
Unobservable
Inputs (Level 3)
 
Liabilities
           
Oramed Note
   $ 104,089      $ —       $ —       $ 104,089  
Convertible Debentures
     4,340        —         —         4,340  
Derivative liabilities
     1,518        —         —         1,518  
Other long-term liabilities
     179        —         —         179  
  
 
 
    
 
 
    
 
 
    
 
 
 
Total liabilities measured at fair value
   $ 110,126      $ —       $ —       $ 110,126  
  
 
 
    
 
 
    
 
 
    
 
 
 
 
    
December 31, 2022
 
    
Balance
    
Quoted Prices
in Active
Markets
(Level 1)
    
Significant
Other
Observable
Inputs (Level 2)
    
Significant
Unobservable
Inputs (Level 3)
 
Liabilities
           
Derivative liabilities
   $ 1,231      $ —       $ —       $ 1,231  
Other long-term liabilities
     163        —         —         163  
  
 
 
    
 
 
    
 
 
    
 
 
 
Total liabilities measured at fair value
   $ 1,394      $ —       $ —       $ 1,394  
  
 
 
    
 
 
    
 
 
    
 
 
 
Schedule of convertible debentures A summary of inputs used in valuing the Convertible Debentures is as follows:
 
    
December 31,
2023
 
Risk -Free Rate
     5.31
Corporate Bond Yield
     15.60
Coupon Interest Rate
     7.0
Volatility
     70.0
Dividend Yield
     0.0
Conversion Price
   $ 8.00  
Schedule of the derivative liabilities measured at fair value using significant unobservable inputs Level 3
The following table includes a summary of the derivative liabilities measured at fair value during the three years ended December 31, 2023, 2022 and 2021 (in thousands):
 
    
Fair Value
 
Ending Balance as of December 31, 2020
   $ 35,400  
Re-measurement
of fair value
     300  
  
 
 
 
Ending Balance as of December 31, 2021
     35,700  
Private warrant liability acquired as part of the Business Combination
     2,545  
Forfeiture of Private Warrants
     1,696  
Change in fair value measurement
     (38,710
  
 
 
 
Ending Balance as of December 31, 2022
     1,231  
Change in fair value measurement
     512  
Forfeiture of Private Warrants
     (225
  
 
 
 
Ending Balance as of December 31, 2023
   $ 1,518  
  
 
 
 
Schedule of quantitative information regarding Level 3 fair value measurements
    
December 31,
2023
   
December 31,
2022
 
Equity value
   $ 2.04     $ 3.99  
Exercise price
   $ 11.50     $ 11.50  
Term, in years
     3.86       4.86  
Volatility
     76.0     35.0
Risk-free rate
     3.90     3.94
Dividend yield
     0.0     0.0
Call option value
   $ 0.42     $ 0.30